| 摘要 |
The present invention is directed towards a novel crystalline form of olm esartan medoxomil, to methods for preparing the compound, to compositionscom prising the compound, and to the use of said compound and compositions for t he treatment or prevention of an angiotensin II receptor mediated disorder, in particular hypertension.
|
